Oncosil Medical Ltd (OSL) - Total Assets

Latest as of December 2025: AU$7.13 Million AUD ≈ $5.05 Million USD

Based on the latest financial reports, Oncosil Medical Ltd (OSL) holds total assets worth AU$7.13 Million AUD (≈ $5.05 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check OSL capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Oncosil Medical Ltd - Total Assets Trend (2005–2025)

This chart illustrates how Oncosil Medical Ltd's total assets have evolved over time, based on quarterly financial data. Check Oncosil Medical Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Oncosil Medical Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Oncosil Medical Ltd's total assets of AU$7.13 Million consist of 94.1% current assets and 5.9% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	71.5%
Accounts Receivable	AU$1.20 Million	16.9%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$424.29K	5.9%
Intangible Assets	AU$0.00	0.0%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Oncosil Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Oncosil Medical Ltd stock valuation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Oncosil Medical Ltd's current assets represent 94.1% of total assets in 2025, a decrease from 97.0% in 2005.
Cash Position: Cash and equivalents constituted 71.5% of total assets in 2025, down from 93.8% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
Asset Diversification: The largest asset category is accounts receivable at 16.9% of total assets.

Oncosil Medical Ltd Competitors by Total Assets

Key competitors of Oncosil Medical Ltd based on total assets are shown below.

Company	Country	Total Assets
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Inspire Medical Systems Inc NYSE:INSP	USA	$911.38 Million
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$90.55 Million
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	China	CN¥1.59 Billion
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	China	CN¥805.10 Million
Stratec SE XETRA:SBS	Germany	€443.38 Million
Scandinavian Medical Solutions AS CO:SMSMED	Denmark	Dkr205.86 Million
Duearity AB ST:DEAR	Sweden	Skr10.84 Million

Oncosil Medical Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.05	3.81	9.47
Quick Ratio	2.05	3.81	9.47
Cash Ratio	0.00	2.92	9.02
Working Capital	AU$3.45 Million	AU$8.17 Million	AU$16.88 Million

Oncosil Medical Ltd - Advanced Valuation Insights

This section examines the relationship between Oncosil Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.51
Latest Market Cap to Assets Ratio	1.85
Asset Growth Rate (YoY)	6.4%
Total Assets	AU$7.15 Million
Market Capitalization	$13.22 Million USD

Valuation Analysis

Above Book Valuation: The market values Oncosil Medical Ltd's assets above their book value (1.85x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Oncosil Medical Ltd's assets grew by 6.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Oncosil Medical Ltd (2005–2025)

The table below shows the annual total assets of Oncosil Medical Ltd from 2005 to 2025.

Year	Total Assets	Change
2025-06-30	AU$7.15 Million ≈ $5.06 Million	+6.40%
2024-06-30	AU$6.72 Million ≈ $4.75 Million	-41.45%
2023-06-30	AU$11.47 Million ≈ $8.12 Million	-12.21%
2022-06-30	AU$13.07 Million ≈ $9.25 Million	-7.64%
2021-06-30	AU$14.15 Million ≈ $10.01 Million	-41.19%
2020-06-30	AU$24.06 Million ≈ $17.02 Million	+106.20%
2019-06-30	AU$11.67 Million ≈ $8.26 Million	-41.31%
2018-06-30	AU$19.88 Million ≈ $14.07 Million	+68.42%
2017-06-30	AU$11.80 Million ≈ $8.35 Million	-25.74%
2016-06-30	AU$15.90 Million ≈ $11.25 Million	+114.62%
2015-06-30	AU$7.41 Million ≈ $5.24 Million	-23.13%
2014-06-30	AU$9.64 Million ≈ $6.82 Million	+54.34%
2013-06-30	AU$6.24 Million ≈ $4.42 Million	+147.41%
2012-06-30	AU$2.52 Million ≈ $1.79 Million	-16.71%
2011-06-30	AU$3.03 Million ≈ $2.14 Million	+2.41%
2010-06-30	AU$2.96 Million ≈ $2.09 Million	-43.41%
2009-06-30	AU$5.23 Million ≈ $3.70 Million	-15.23%
2008-06-30	AU$6.17 Million ≈ $4.36 Million	-11.92%
2007-06-30	AU$7.00 Million ≈ $4.95 Million	-14.45%
2006-06-30	AU$8.18 Million ≈ $5.79 Million	+764.63%
2005-06-30	AU$946.59K ≈ $669.77K	--

About Oncosil Medical Ltd

AU:OSL Australia Medical Devices

Market Cap

$13.28 Million

AU$18.77 Million AUD

Market Cap Rank

#26344 Global

#1221 in Australia

Share Price

AU$0.80

Change (1 day)

+34.75%

52-Week Range

AU$0.39 - AU$1.99

All Time High

AU$1.99